SK

Satish Chandra Khanna

NF Novartis Finance: 4 patents #23 of 193Top 15%
NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
CI Ciba-Geigy: 1 patents #1,572 of 2,867Top 55%
📍 Bottmingen, CH: #25 of 97 inventorsTop 30%
Overall (All Time): #663,859 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
6565883 Controlled release oral compositions comprising rivastigmine Jorg Ogorka, Oskar Kalb, Rajen Shah 2003-05-20
6300519 Antivirally active heterocyclic azahexane derivatives Alexander Fassler, Guido Bold, Hans-Georg Capraro, Marc Lang 2001-10-09
6166004 Combinations of HIV protease inhibitors with reverse transcriptase inhibitors Alexander Fassler, Guido Bold, Hans-Georg Capraro, Marc Lang 2000-12-26
6110946 Antivirally active heterocyclic azahexane derivatives Alexander Fassler, Guido Bold, Hans-Georg Capraro, Marc Lang 2000-08-29
5935976 Antiviral ethers of aspartate protease substrate isosteres Guido Bold, Hans-Georg Capraro, Alexander Fassler, Marc Lang, Shripad S. Bhagwat +2 more 1999-08-10
5849911 Antivirally active heterocyclic azahexane derivatives Alexander Fassler, Guido Bold, Hans-Georg Capraro, Marc Lang 1998-12-15
5807891 Antiviral ethers of aspartate protease substrate isosteres Guido Bold, Hans-Georg Capraro, Alexander Fassler, Marc Lang, Shripad S. Bhagwat +2 more 1998-09-15
5663200 Antiviral ethers of aspartate protease substrate isosteres Guido Bold, Hans-Georg Capraro, Alexander Fassler, Marc Lang, Shripad S. Bhagwat +2 more 1997-09-02